The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment

Abstract

We studied the effect of intravenous methylprednisolone (MP) on the expression of the integrins, LFA-1 and VLA-4, on activated blood T-lymphocytes in 17 patients with relapses of clinically definite relapsing-remitting MS. MP treatment did not induce changes in the expression of CD3, CD4, DR, LFA-1 or VLA-4 markers when measured in the total population of lymphocytes in MS patients in relation to treatment. Treatment influenced neither the LFA-1 nor VLA-4 positive cells within the CD3+ population. MP treatment clearly decreased the DR+ CD3+ cells (P50.01) and the percentage of DR+ CD3+ lymphocytes bearing VLA-4 (P50.01). However, this was not the case when we studied the percentage of lymphocytes which expressed LFA-1. Glucocorticoids did not influence the mean intensity of the expression of the two integrins quantified in either total or DR+ CD3+ lymphocytes. Although, further research seems warranted to investigate a possible effect of MP on lymphocyte integrin function, this work corroborates the idea that MP treatment may interfere with the mechanisms of T-cell migration into CNS, thus modulating the activity of multiple sclerosis.

Keywords

multiple sclerosis integrins VLA-4 LFA-1 adhesion molecules methylprednisolone

Get full access to this article

View all access options for this article.

References

Storch M , Lassmann H. (1997) Pathology and pathogenesis of demyelinating diseases . Curr Opin Neurol 10: 186-192 .

Hickey WF , Hsu BL , Kimura H. (1991) T-lymphocyte entry into the central nervous system . J Neurosci Res 28: 254-260 .

Pryce G , Male D , Campbell Y , Greenwood J. (1997) Factors controlling T-cell migration across rat cerebral endothelium in vitro . J Neuroimmunol 75: 84-94 .

Yednock TA et al. (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against a4b1 integrin . Nature 356: 63-66 .

Pitzalis C et al. (1997) Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis . J Neuroimmunol 74: 62-68 .

Malinowsky K et al. (1992) Homing of CD8CD57 T lymphocyte into acutely rejected renal allografts . Transplantation 54: 1013-1017 .

Cannella B , Raine CS. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions . Ann Neurol 37: 424-435 .

Stüber A et al. (1996) Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis . J Neuroimmunol 66: 147-151 .

Milligan NM , Newcombe R , Compston DAS. (1987) A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1 Clinical effects . J Neurol Neurosurg Psychiatry 50: 511-516 .

10.

Barkhof F , Hommes OR , Scheltens P , Valk J. (1991) Quantitative MRI changes in gadolinium DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis . Neurology 41: 1219-1222 .

11.

Salle JY et al. (1992) Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis . J Neurol Sci 108: 184-188 .

12.

Kupersmith MJ et al. (1994) Megadose corticosteroids in multiple sclerosis . Neurology 44: 1-4 .

13.

Baron JL et al. (1993) Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma . J Exp Med 177: 57-68 .

14.

Salmi M , Jalkanen S. (1997) How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing . Adv Immunol 64: 139-218 .